Biotech companies have signed leases in three different office hubs in a slew of deals that suggest life science firms continue to seek expansion space despite widening uncertainties about commercial real estate.
Biotech companies have signed leases in three different office hubs in a slew of deals that suggest life science firms continue to seek expansion space despite widening uncertainties about commercial real estate.